跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIO-ZOLMITRIPTAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIO-ZOLMITRIPTAN
Authorized
STANDARD
BIO-ZOLMITRIPTAN
biomed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2d9d72e46fd0531b
Company
biomed pharma
Type
Standard
Approval Details
Approval Id
2d9d72e46fd0531b
Drug Approval Canada Name
BIO-ZOLMITRIPTAN
Product Name
BIO-ZOLMITRIPTAN
Status
Marketed
Status Date
2023-01-11
Original Market Date
2023-01-11
Din
02512831
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:32.28
Atc Original
N02CC03 ZOLMITRIPTAN
Atc Name
n 02 cc 03
Aig Number
0134381001
Company Name
biomed pharma
Company Address
1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8
Active Ingredients
ZOLMITRIPTAN
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2d9d72e46fd0531b
Type
Standard
Back to Health Canada Approvals